1Angus DC,Linde.Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the united states:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29(7):1303-1310.
2Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM consensus conference committee.American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101(6):1644-1665.
4Lundberg JS,Perl TM,Wiblin T,et al.Septic shock:an analysis of outcomes for patients with onset on hospital wards versus intensive care units[J].Crit Care Med,1998,26(6):1020-1024.
5Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Eng J Med,2001,345(19):1368-1377.
6Levy MM,Fink MP,Marshall JC,et al.2001SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J].Crit Care Med,2003,31(4):1250-1256.
7Harbarth S,Holeckova K,Froidevaux C,et al.Diagnostic value of procalcitonin,interleukin-6,and interleukin-8 in critically ill patients admitted with suspected sepsis[J].Am J Respire Crit Care Med,2001,164(3):396-402.
9Morgenthaler NG,Struck J,Alonso C,et al.Measurement of midregional proad-renomedullin in plasma with an immunoluminometric assay[J].Clin Chen,2005,51(10):1823-1829.
10Christ-Crain M,Morgenthaler NG,Struck J,et al.Mid-regional pro-ADM as a prognostic marker in sepsis:an observational study[J].Crit Care,2005,9(6):816-824.
8Qiao LD,Chen S, Yang Y, et al. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study[J]. BMJ Open,2013,3(12) :e004152.
9Guerin S.Evaluation of the detection of procalcitonin by animmunochromatography test:brahms PCT-Q[J].Ann Biol Clin(Paris),2000,58(5):613-614.
10Harrison M,Collins CD.Is procalcitonin guided antimicrobial use cost effective in adult patients with suspected bacterial infection and sepsis[J].Infect Control Hospepidemiol,2015,36:265-272.
